- Home
- SPLP vs CMRX Comparison
SPLP vs CMRX Comparison
Compare SPLP & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPLP
- CMRX
- Stock Information
- Founded
- SPLP 1990
- CMRX 2000
- Country
- SPLP United States
- CMRX United States
- Employees
- SPLP N/A
- CMRX N/A
- Industry
- SPLP Industrial Specialties
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SPLP Industrials
- CMRX Health Care
- Exchange
- SPLP Nasdaq
- CMRX Nasdaq
- Market Cap
- SPLP 731.7M
- CMRX 797.3M
- IPO Year
- SPLP N/A
- CMRX 2013
- Fundamental
- Price
- SPLP $33.63
- CMRX $8.54
- Analyst Decision
- SPLP
- CMRX Hold
- Analyst Count
- SPLP 0
- CMRX 4
- Target Price
- SPLP N/A
- CMRX $8.51
- AVG Volume (30 Days)
- SPLP 10.3K
- CMRX 2.0M
- Earning Date
- SPLP 05-07-2025
- CMRX 04-30-2025
- Dividend Yield
- SPLP N/A
- CMRX N/A
- EPS Growth
- SPLP 76.92
- CMRX N/A
- EPS
- SPLP 11.38
- CMRX N/A
- Revenue
- SPLP $2,027,848,000.00
- CMRX $212,000.00
- Revenue This Year
- SPLP N/A
- CMRX $2,416.04
- Revenue Next Year
- SPLP N/A
- CMRX $923.92
- P/E Ratio
- SPLP $2.95
- CMRX N/A
- Revenue Growth
- SPLP 6.42
- CMRX N/A
- 52 Week Low
- SPLP $27.95
- CMRX $0.75
- 52 Week High
- SPLP $48.45
- CMRX $8.55
- Technical
- Relative Strength Index (RSI)
- SPLP 34.84
- CMRX 80.86
- Support Level
- SPLP $32.30
- CMRX $8.50
- Resistance Level
- SPLP $41.00
- CMRX $8.55
- Average True Range (ATR)
- SPLP 2.03
- CMRX 0.02
- MACD
- SPLP -0.74
- CMRX -0.12
- Stochastic Oscillator
- SPLP 40.80
- CMRX 88.89
About SPLP Steel Partners Holdings LP LTD PARTNERSHIP UNIT
Steel Partners Holdings LP operates in industrial products, energy, defense, supply chain management and logistics, banking, and youth sports industries. Its segments include the Diversified Industrial segment comprised of manufacturers of engineered niche industrial products, joining materials, tubing, building materials, performance materials etc; the Energy segment provides drilling and production services to the oil and gas industry and owns a youth sports business; the Financial Services segment consists of the operations of WebBank, a Utah chartered industrial bank, which engages in full range of banking activities; The Supply Chain segment consists of end-to-end world-wide supply; and Corporate and Other consists of equity method and other investments, and cash and cash equivalents.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.